Psychedelic Science 2025: Lessons From MDMA Trials Could Strengthen Future Psychedelic Approvals
July 28th 2025Joel Stanley of Ajna Biosciences reflects on the regulatory challenges surrounding MDMA-assisted therapy, outlines lessons for future psychedelic drug trials, and emphasizes the importance of scientific rigor, interdisciplinary infrastructure, and the evolving role of pharmacists in ensuring safe clinical integration.
Psychedelic Science 2025: Clinical Perspectives on Psychedelics in Palliative Oncology
June 16th 2025Manish Agrawal, MD, discusses emerging research on psychedelic-assisted therapy for patients with cancer, including innovative dyadic treatment models, challenges in capturing meaningful outcomes, and growing interest in integrating psychedelics into oncology and palliative care.